SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
21-Jun-24 5:00 PM View: | Uniqure N.V. (QURE) | 19-Jun-24 | Grant | 8,080 | -- | -- | 51% 16.0K to 24.08K | |
18-Jun-24 6:11 PM View: | Uniqure N.V. (QURE) | 13-Jun-24 | Sale | 2,222 | $5.14 | $11,421.10 | (12%) 18.22K to 16.0K | |
01-Mar-23 4:19 PM View: | Uniqure N.V. (QURE) | 27-Feb-23 | Market Sale | 389 | $19.73 | $7,674.97 | (3%) 12.2K to 11.81K | 1% |
03-Aug-22 5:44 PM View: | Fulgent Genetics, Inc. (FLGT) | 01-Aug-22 | Grant | 8,000 | -- | -- | 100% 0 to 8.0K | |
17-Jun-22 4:59 PM View: | Uniqure N.V. (QURE) | 15-Jun-22 | Grant | 9,080 | -- | -- | 291% 3.12K to 12.2K | |
02-Mar-22 5:45 PM View: | Uniqure N.V. (QURE) | 28-Feb-22 | Sale | 795 | $16.64 | $13,228.80 | (20%) 3.92K to 3.12K | |
28-Feb-22 6:43 PM View: | Uniqure N.V. (QURE) | 24-Feb-22 | Grant | 1,534 | -- | -- | 64% 2.38K to 3.92K | |
01-Mar-21 4:30 PM View: | Uniqure N.V. (QURE) | 25-Feb-21 | Grant | 2,382 | -- | -- | 100% 0 to 2.38K | |
27-Apr-04 10:00 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 26-Apr-04 | Option Exercise | 8,000 | $10.00 | $80,000.00 | 54% 14.73K to 22.73K | |
27-Apr-04 10:00 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 26-Apr-04 | Market Option Sale | 8,000 | $56.29 | $450,354.00 | (35%) 22.73K to 14.73K | (116%) |
29-Mar-04 10:00 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 26-Mar-04 | Option Exercise | 10,000 | $10.00 | $100,000.00 | 68% 14.73K to 24.73K | |
29-Mar-04 10:00 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 26-Mar-04 | Market Option Sale | 10,000 | $39.51 | $395,059.00 | (40%) 24.73K to 14.73K | (208%) |
23-Mar-04 10:00 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 22-Mar-04 | Option Exercise | 10,000 | $10.00 | $100,000.00 | 68% 14.73K to 24.73K | |
23-Mar-04 10:00 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 22-Mar-04 | Market Option Sale | 10,000 | $36.02 | $360,208.00 | (40%) 24.73K to 14.73K | (238%) |